妊娠期药物安全监测:国家药物警戒中心的国际活动、未来意向与支持需求
该研究通过问卷调研发送给172个国家的药物警戒中心,应答率40%,了解其在妊娠期药物安全监测方面的当前活动、未来意向和支持需求。结果显示各中心收到的妊娠期药物暴露相关(未出生)儿童ADR报告数量有限,58个中心中仅8个(13.5%)开展妊娠病例信号检测,但多数中心有意向实施或改进活动,主为自发报告(69.4%)和信号检测方法(67.2%),所有主题均需支持。
要点
- 妊娠期药物暴露相关儿童ADR报告数量有限,信号检测开展率低(8/58,13.5%)。
- 多数中心有意向改进活动,主为自发报告(69.4%)和信号检测方法(67.2%)。
- 所有问卷主题均需支持,应建立项目支持和激励药物警戒中心。
核心结论
- 国家药物警戒中心在妊娠期药物安全监测方面的当前活动有限。
- 多数中心愿意改进或实施活动,需建立项目支持和激励。
研究设计与样本
- 采用网络问卷调研发送给172个国家的药物警戒中心,应答率40%。
- 问卷涵盖自发ADR报告、获取信息的额外活动、信号检测以及告知医疗专业人员和公众。
主要发现
- 药物警戒中心收到的妊娠期药物暴露相关(未出生)儿童ADR报告数量有限。
- 58个中心中8个(13.5%)开展妊娠病例信号检测。
- 多数中心有意向实施或改进活动,主为自发报告(69.4%)和信号检测方法(67.2%)。
- 所有问卷主题均需要支持。
临床怎么用
- 临床药师可关注所在机构妊娠期药物暴露ADR的上报完整性,以支持药物警戒中心信号检测。
- 可参考多数中心意向重点,优先完善妊娠期自发报告和信号检测方法。
局限性
- 问卷应答率为40%,可能影响结果的代表性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Surveillance of drug safety during pregnancy is a special interest of pharmacovigilance (PV). The role that national PV centres take in this field is, however, unclear. AIM: The aim of this study was to provide insight into current activities, future intentions and need for support of national PV centres in the field of drug safety during pregnancy. METHOD: A web-based questionnaire was used to ask PV centres about their current activities concerning the surveillance of drug safety during pregnancy, their intentions to implement or improve activities and need for support. For these three main topics, questions were posed about spontaneous adverse drug reaction (ADR) reporting, additional activities to obtain information, signal detection and informing healthcare professionals and the public. RESULTS: The questionnaire was sent to PV centres of 172 countries. Response was 40%. In general, the PV centres received limited numbers of reports of ADRs in the (unborn) child, related to drug exposure during pregnancy. Signal detection in pregnancy cases is carried out by 8 out of 58 PV centres (13.5%). Most PV centres mention they have intentions to implement or improve activities, mainly for spontaneous reporting (69.4%) and methods for signal detection (67.2%). Support was needed for all topics of the questionnaire. CONCLUSION: Current activities of national PV centres concerning drug safety during pregnancy are limited. The majority of PV centres are, however, willing to improve or implement activities. Programmes should be set up in order to support and stimulate PV centres with these activities. The aim of all these activities is to increase knowledge about the safety of drugs during pregnancy.
引用
- Kant A, de Vries L, Rolfes L, et al. Surveillance of Drug Safety During Pregnancy: Insight in Current International Activities, Future Intentions and Need for Support of National Pharmacovigilance Centres. Drug Saf. 2019. PMID: 30284215. doi:10.1007/s40264-018-0729-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。